Clinical Trials Browser

Lymphoma, T-Cell, Peripheral × nilotinib × Clear all

NCT01155817 2020-04-15

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Phase 1 Completed

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral